Growing community of inventors

Kanagawa, Japan

Tomoko Matsukawa

Average Co-Inventor Count = 9.17

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 1

Tomoko MatsukawaKenji Hirai (4 patents)Tomoko MatsukawaTomoyuki Yano (4 patents)Tomoko MatsukawaTomoko Yoshii (4 patents)Tomoko MatsukawaSadayuki Ugai (3 patents)Tomoko MatsukawaOsamu Yamada (3 patents)Tomoko MatsukawaEmiko Ejiri (2 patents)Tomoko MatsukawaKiyomi Aizawa (2 patents)Tomoko MatsukawaKatsuyuki Masuda (2 patents)Tomoko MatsukawaTakehito Mouri (2 patents)Tomoko MatsukawaShigeki Kishi (2 patents)Tomoko MatsukawaKoichi Shikakura (2 patents)Tomoko MatsukawaNatsuko Okano (1 patent)Tomoko MatsukawaKiyomi Imai (1 patent)Tomoko MatsukawaRyuta Ohno (1 patent)Tomoko MatsukawaTomoko Matsukawa (4 patents)Kenji HiraiKenji Hirai (29 patents)Tomoyuki YanoTomoyuki Yano (10 patents)Tomoko YoshiiTomoko Yoshii (4 patents)Sadayuki UgaiSadayuki Ugai (6 patents)Osamu YamadaOsamu Yamada (6 patents)Emiko EjiriEmiko Ejiri (9 patents)Kiyomi AizawaKiyomi Aizawa (6 patents)Katsuyuki MasudaKatsuyuki Masuda (3 patents)Takehito MouriTakehito Mouri (2 patents)Shigeki KishiShigeki Kishi (2 patents)Koichi ShikakuraKoichi Shikakura (2 patents)Natsuko OkanoNatsuko Okano (3 patents)Kiyomi ImaiKiyomi Imai (1 patent)Ryuta OhnoRyuta Ohno (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Sagami Chemical Research Center (4 from 191 patents)

2. Kaken Pharmaceutical Company, Ltd. (4 from 136 patents)


4 patents:

1. 6090946 - Process for the preparation of 3-(substituted

2. 5612289 - 4-imino-oxazolidine-2-one derivatives, a process for producing such

3. 5554581 - Tetrahydrophthalamide derivative, intermediate for producing the same,

4. 5506190 - Tetrahydrophthalamide derivative, intermediate for producing the same,

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/5/2025
Loading…